Although studies on non-early albumin combination therapy in isolated ischemic stroke are lacking, these findings are consistent with our observation that early albumin combination therapy was not associated with improved 90-day mortality or shorter ICU and hospital stays in septic patients with ischemic stroke. The gene discussed is ALB; the disease is ischemic stroke.